Nektar Therapeutics
NKTR
#5687
Rank
C$1.59 B
Marketcap
C$78.61
Share price
-1.37%
Change (1 day)
266.42%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): C-$5.94

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$5.84. In 2024 the company made an earnings per share (EPS) of C-$4.84 an increase over its 2023 EPS that were of C-$30.25.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$5.9422.95%
2024C-$4.84-84.02%
2023C-$30.25-25.89%
2022C-$40.82-31.12%
2021C-$59.2714.86%
2020C-$51.60-1.19%
2019C-$52.22-163.96%
2018C$81.65-725.4%
2017C-$13.06-42.73%
2016C-$22.7983.33%
2015C-$12.4339.53%
2014C-$8.91-69.29%
2013C-$29.01-6.67%
2012C-$31.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
C$18.00-408.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$2.38-140.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.49-279.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
C$0.01382-100.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$4.19-171.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
C-$0.91-84.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
C$2.86-148.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
C$14.42-346.79%๐Ÿ‡บ๐Ÿ‡ธ USA